Activated c-SRC in ductal carcinoma in situ correlates with high tumour grade, high proliferation and HER2 positivity
Open Access
- 24 October 2006
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 95 (10) , 1410-1414
Abstract
Overexpression and/or activity of c-Src non-receptor tyrosine kinase is associated with progression of several human epithelial cancers including breast cancer. c-Src activity in ‘pure’ ductal carcinoma in situ (DCIS) was measured to assess whether this predicts recurrence and/or correlates with HER2 expression and other clinical parameters. Activated c-Src levels were evaluated in DCIS biopsies from 129 women, with median follow-up at 60 months. High levels of activated c-Src correlated with HER2 positivity, high tumour grade, comedo necrosis and elevated epithelial proliferation. In univariate analysis, high activated c-Src level associated with lower recurrence-free survival at 5 years (P=0.011). Thus, high c-Src activity may identify a subset of DCIS with high risk of recurrence or progression to invasive cancer where therapeutics targeting c-Src may benefit this patient subset.Keywords
This publication has 26 references indexed in Scilit:
- Role of c-Src and focal adhesion kinase in progression and metastasis of estrogen receptor-positive breast cancerBiochemical and Biophysical Research Communications, 2006
- Activation of Stat3 in Primary Tumors from High-Risk Breast Cancer Patients Is Associated with Elevated Levels of Activated Src and Survivin ExpressionClinical Cancer Research, 2006
- Absence of HER4 Expression Predicts Recurrence of Ductal Carcinoma In situ of the BreastClinical Cancer Research, 2005
- ErbB2 Promotes Src Synthesis and Stability: Novel Mechanisms of Src Activation That Confer Breast Cancer MetastasisCancer Research, 2005
- Construction and characterization of multiple human colon cancer cell lines for inducibly regulated gene expressionJournal of Cellular Biochemistry, 2005
- A renaissance for SRCNature Reviews Cancer, 2004
- COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situBritish Journal of Cancer, 2004
- C-Src Activation by ErbB2 Leads to Attachment-Independent Growth of Human Breast Epithelial CellsBiochemical and Biophysical Research Communications, 1998
- A New Monoclonal Antibody Which Selectively Recognizes the Active Form of Src Tyrosine KinaseJournal of Biological Chemistry, 1996
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/neuOncogeneScience, 1987